| 发明名称 |
HCV neutralizing epitopes |
| 摘要 |
The invention relates to modified hepatitis C virus E2 polypeptides that are effective in eliciting the production of cross-neutralizing antibodies against hepatitis C virus. The invention provides modified hepatitis C virus E2 polypeptides, preparations and pharmaceutical compositions containing them, as well as methods for using these modified E2 polypeptides.
|
| 申请公布号 |
US2010104555(A1) |
申请公布日期 |
2010.04.29 |
| 申请号 |
US20080290017 |
申请日期 |
2008.10.24 |
| 申请人 |
THE SCRIPPS RESEARCH INSTITUTE |
发明人 |
LAW MANSUN;MARUYAMA TOSHIAKI;BURTON DENNIS R.;BALL JONATHAN K.;KNETEMAN NORMAN M. |
| 分类号 |
A61K38/17;A61K31/7088;A61K38/16;A61K39/395;A61P31/12;C07H21/04;C07K16/00;C12N1/21;C12N5/10;C12N15/63;C12Q1/70 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
